Celgene to buy back additional $5B of shares

|About: Celgene Corporation (CELG)|By:, SA News Editor

Celgene's (NASDAQ:CELG) board has authorized the repurchase of an additional $5B of the company's common stock in open-market transactions. The program is open-ended so no specific termination date applies.

Subscribe for full text news in your inbox